PTX - Prescient Therapeutics Ltd (ASX) Stock Forum
Prescient Therapeutics Ltd (ASX:PTX) is an Australian biotechnology company that focuses on developing innovative cancer treatments. The company's lead drug candidate, PTX-100, is a first-in-class inhibitor of a protein called Ras, which is commonly mutated in many types of cancer. PTX-100 has shown promising results in preclinical studies and is currently in clinical trials for the treatment of solid tumors and hematological malignancies. As an Aussie stock, PTX may be of interest to traders on our forum who are looking for opportunities in the biotech sector.
